Dosulepin
Structural formula | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cis -form (top) and trans -form (bottom) | |||||||||||||||||||
General | |||||||||||||||||||
Non-proprietary name | Dosulepin | ||||||||||||||||||
other names | |||||||||||||||||||
Molecular formula |
|
||||||||||||||||||
Brief description |
white to pale yellow, crystalline powder (Dosulepin hydrochloride) |
||||||||||||||||||
External identifiers / databases | |||||||||||||||||||
|
|||||||||||||||||||
Drug information | |||||||||||||||||||
ATC code | |||||||||||||||||||
Drug class | |||||||||||||||||||
properties | |||||||||||||||||||
Molar mass | |||||||||||||||||||
solubility |
Easily soluble in water, dichloromethane and ethanol (Dosulepin hydrochloride) |
||||||||||||||||||
safety instructions | |||||||||||||||||||
|
|||||||||||||||||||
Toxicological data | |||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Dosulepin ( INN ) is a drug from the group of tricyclic antidepressants . It is a mixture of cis - and trans - isomer usually used as the hydrochloride.
pharmacology
Pharmacodynamics and pharmacokinetics
Dosulepin has the same effect as Doxepin . It inhibits the reuptake of the neurotransmitters serotonin and norepinephrine , besides it also acts as an antagonist at histamine H 1 - and muscarinic receptor . It has a bioavailability of 30% and a half-life of 20 hours. It is metabolized via the liver.
Side effects
Common side effects (<1%) are: nausea, headache, constipation , dry mouth, sweating, dizziness, drowsiness, gastrointestinal disorders, subtle tremor.
In the event of an overdose, Dosulepin is more toxic than other tricyclics and leads to increased seizures and cardiac arrhythmias.
Indications
Dosulepin is approved for the treatment of inhibited depression . It is used off-label for adjuvant therapy for chronic pain . Therapeutically sensible doses range between 75 and 150 mg daily, in-patient treatment can be increased up to 300 mg if necessary. There is a relative contraindication in patients with cardiovascular disease.
Trade names
Idom (D; since 2014 out of trade), Prothiaden (in some European countries)
- with Diazepam : Harmomed (A) no longer available (September 2016)
Individual evidence
- ↑ a b c Datasheet DOSULEPIN HYDROCHLORIDE CRS (PDF) at EDQM , accessed on December 3, 2009.
- ↑ a b data sheet Dothiepin hydrochloride from Sigma-Aldrich , accessed on April 29, 2011 ( PDF ).
- ^ NA Buckley, AH Dawson, IM Whyte, DA Henry: Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. In: The Lancet . Volume 343, Number 8890, January 1994, pp. 159-162, doi : 10.1016 / s0140-6736 (94) 90940-7 , PMID 7904010 .
- ↑ Benkert, Hippius (ed.): Compendium of psychiatric pharmacotherapy. 6th edition, Springer, Berlin 2007. p. 87. ISBN 3-540-21893-9 .
- ↑ When drugs are misused. August 13, 2015, accessed December 20, 2019 .
- ↑ Index Nominum, online version.
- ↑ AGES-PharmMed, as of June 2010.